Literature DB >> 2484697

Atherosclerosis and responses of human isolated coronary arteries to endothelium-dependent and -independent vasodilators.

G Berkenboom1, P Unger, J Fontaine.   

Abstract

In canine and porcine coronary arteries, experimental atherosclerosis (induced by endothelial denudation followed by a high-cholesterol diet) potentiates the vasoconstrictor effects of histamine, serotonin, and ergonovine. In isolated human atherosclerotic coronary arteries, only hypersensitivity to histamine has been demonstrated. This discrepancy could be due to several factors. First, the atherosclerotic lesions in human vessels are different from those observed in the animal, since experimental atherosclerosis often corresponds only to the early stage of the disease in humans. Second, the human atherosclerotic coronary arteries were isolated mainly from patients with cardiac failure, a condition that alters the responses of coronary smooth muscle to vasoactive amines. With regard to endothelium-dependent vasodilators, marked attenuations of the relaxations to substance P, bradykinin, and the Ca2+ ionophore A23187 have been described in isolated human atherosclerotic arteries. Acetylcholine elicits variable responses in these preparations and even if the arteries are devoid of atherosclerotic lesions, it often fails to relax them. In addition to this endothelial dysfunction, severely atherosclerotic human coronary vessels exhibit a slightly decreased responsiveness to nitroglycerin and SIN-1 but not to forskolin. Another abnormality of the smooth muscle is a marked attenuated beta-adrenergic relaxation. Thus, atherosclerosis of human coronary vessels induces not only marked alterations in endothelium-dependent responses but also modifies the sensitivity to several endothelium-independent vasodilators.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2484697

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

Review 1.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

2.  Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?

Authors:  P Owens; E O'Brien
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

3.  Persistence of PAR-2 vasodilation despite endothelial dysfunction in BPH/2 hypertensive mice.

Authors:  John J McGuire; Bruce N Van Vliet; José Giménez; James C King; Sarah J Halfyard
Journal:  Pflugers Arch       Date:  2007-02-23       Impact factor: 3.657

4.  Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.

Authors:  Bobby Nossaman; Edward Pankey; Philip Kadowitz
Journal:  Crit Care Res Pract       Date:  2012-02-28

5.  Soluble guanylate cyclase redox state under oxidative stress conditions in isolated monkey coronary arteries.

Authors:  Masashi Tawa; Tomio Okamura
Journal:  Pharmacol Res Perspect       Date:  2016-09-16

6.  Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet-fed rabbits.

Authors:  Masashi Tawa; Katsuya Nakano; Yuka Yamashita; Qiang He; Takayoshi Masuoka; Tomio Okamura; Takaharu Ishibashi
Journal:  Pharmacol Res Perspect       Date:  2021-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.